1bx4

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Adenosine kinase (AK) is a key enzyme in the regulation of extracellular, adenosine and intracellular adenylate levels. Inhibitors of adenosine, kinase elevate adenosine to levels that activate nearby adenosine, receptors and produce a wide variety of therapeutically beneficial, activities. Accordingly, AK is a promising target for new analgesic, neuroprotective, and cardioprotective agents. We determined the structure, of human adenosine kinase by X-ray crystallography using MAD phasing, techniques and refined the structure to 1.5 A resolution. The enzyme, structure consisted of one large alpha/beta domain with nine beta-strands, eight alpha-helices, and one small alpha/beta-domain with five, beta-strands and two alpha-helices. The active site is formed along the, edge of the beta-sheet in the large domain while the small domain acts as, a lid to cover the upper face of the active site. The overall structure is, similar to the recently reported structure of ribokinase from Escherichia, coli [Sigrell et al. (1998) Structure 6, 183-193]. The structure of, ribokinase was determined at 1.8 A resolution and represents the first, structure of a new family of carbohydrate kinases. Two molecules of, adenosine were present in the AK crystal structure with one adenosine, molecule located in a site that matches the ribose site in ribokinase and, probably represents the substrate-binding site. The second adenosine site, overlaps the ADP site in ribokinase and probably represents the ATP site., A Mg2+ ion binding site is observed in a trough between the two adenosine, sites. The structure of the active site is consistent with the observed, substrate specificity. The active-site model suggests that Asp300 is an, important catalytic residue involved in the deprotonation of the, 5'-hydroxyl during the phosphate transfer.
+
Adenosine kinase (AK) is a key enzyme in the regulation of extracellular adenosine and intracellular adenylate levels. Inhibitors of adenosine kinase elevate adenosine to levels that activate nearby adenosine receptors and produce a wide variety of therapeutically beneficial activities. Accordingly, AK is a promising target for new analgesic, neuroprotective, and cardioprotective agents. We determined the structure of human adenosine kinase by X-ray crystallography using MAD phasing techniques and refined the structure to 1.5 A resolution. The enzyme structure consisted of one large alpha/beta domain with nine beta-strands, eight alpha-helices, and one small alpha/beta-domain with five beta-strands and two alpha-helices. The active site is formed along the edge of the beta-sheet in the large domain while the small domain acts as a lid to cover the upper face of the active site. The overall structure is similar to the recently reported structure of ribokinase from Escherichia coli [Sigrell et al. (1998) Structure 6, 183-193]. The structure of ribokinase was determined at 1.8 A resolution and represents the first structure of a new family of carbohydrate kinases. Two molecules of adenosine were present in the AK crystal structure with one adenosine molecule located in a site that matches the ribose site in ribokinase and probably represents the substrate-binding site. The second adenosine site overlaps the ADP site in ribokinase and probably represents the ATP site. A Mg2+ ion binding site is observed in a trough between the two adenosine sites. The structure of the active site is consistent with the observed substrate specificity. The active-site model suggests that Asp300 is an important catalytic residue involved in the deprotonation of the 5'-hydroxyl during the phosphate transfer.
==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Ealick, S.E.]]
+
[[Category: Ealick, S E.]]
-
[[Category: Erion, M.D.]]
+
[[Category: Erion, M D.]]
-
[[Category: Mathews, I.I.]]
+
[[Category: Mathews, I I.]]
[[Category: ADN]]
[[Category: ADN]]
[[Category: CL]]
[[Category: CL]]
Line 22: Line 22:
[[Category: human adenosine kinase]]
[[Category: human adenosine kinase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 09:34:11 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:00:00 2008''

Revision as of 10:00, 21 February 2008


1bx4, resolution 1.50Å

Drag the structure with the mouse to rotate

STRUCTURE OF HUMAN ADENOSINE KINASE AT 1.50 ANGSTROMS

Overview

Adenosine kinase (AK) is a key enzyme in the regulation of extracellular adenosine and intracellular adenylate levels. Inhibitors of adenosine kinase elevate adenosine to levels that activate nearby adenosine receptors and produce a wide variety of therapeutically beneficial activities. Accordingly, AK is a promising target for new analgesic, neuroprotective, and cardioprotective agents. We determined the structure of human adenosine kinase by X-ray crystallography using MAD phasing techniques and refined the structure to 1.5 A resolution. The enzyme structure consisted of one large alpha/beta domain with nine beta-strands, eight alpha-helices, and one small alpha/beta-domain with five beta-strands and two alpha-helices. The active site is formed along the edge of the beta-sheet in the large domain while the small domain acts as a lid to cover the upper face of the active site. The overall structure is similar to the recently reported structure of ribokinase from Escherichia coli [Sigrell et al. (1998) Structure 6, 183-193]. The structure of ribokinase was determined at 1.8 A resolution and represents the first structure of a new family of carbohydrate kinases. Two molecules of adenosine were present in the AK crystal structure with one adenosine molecule located in a site that matches the ribose site in ribokinase and probably represents the substrate-binding site. The second adenosine site overlaps the ADP site in ribokinase and probably represents the ATP site. A Mg2+ ion binding site is observed in a trough between the two adenosine sites. The structure of the active site is consistent with the observed substrate specificity. The active-site model suggests that Asp300 is an important catalytic residue involved in the deprotonation of the 5'-hydroxyl during the phosphate transfer.

About this Structure

1BX4 is a Single protein structure of sequence from Homo sapiens with , and as ligands. Active as Adenosine kinase, with EC number 2.7.1.20 Known structural/functional Sites: and . Full crystallographic information is available from OCA.

Reference

Structure of human adenosine kinase at 1.5 A resolution., Mathews II, Erion MD, Ealick SE, Biochemistry. 1998 Nov 10;37(45):15607-20. PMID:9843365

Page seeded by OCA on Thu Feb 21 12:00:00 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools